BACKGROUND: Mild to moderate hearing loss is common in patients with mucopolysaccharidosis (MPS) IVA. The hearing loss can be conductive, sensorineural, or mixed. However, in these patients, the mixed form is frequent, attributed to the combination of conductive and neurosensory elements, with slowly progressive evolution. Conductive hearing loss may be secondary to recurrent upper respiratory tract infections, serous otitis media, and deformities of the ear ossicles due to the accumulation of glycosaminoglycans (GAGs). Meanwhile, the sensorineural form is mainly attributed to the accumulation of GAGs in the auditory system. OBJECTIVE: The aim of this scoping review is to understand the extent and type of evidence in relation to the physiopathology, classification, epidemiology, and clinical management of hearing loss and the effect of therapy for hearing loss in patients with MPS IVA. METHODS: This scoping review includes participants across all genders and of no particular age group who are diagnosed with MPS IVA and develop hearing loss as a comorbidity. No exclusion criteria (country, language, or document type) will be applicable. The information sources will include experimental and quasi-experimental, analytical observational, observational, and qualitative studies. Unpublished literature will not be covered. Grey literature will be covered. A total of 2 independent reviewers will participate in the process of screening the literature, paper selection, and data extraction, and this process will be performed blindly. When all manuscripts have been selected, disagreements that arise between the 2 reviewers at each stage of the selection process will be resolved through discussion or with an additional reviewer. Results will be reported with descriptive statistics and information will be displayed in a diagrammatic or tabular manner, as explained in the JBI guidelines. RESULTS: The literature search was performed in November 2021 in MEDLINE, LILACS (Literatura Latino-Americana e do Caribe em Ciências da Saúde), the Cochrane Library, ScienceDirect, Google Scholar, and OpenGrey; a total of 780 results were retrieved. Completion of the review is expected in mid-2022. CONCLUSIONS: This scoping review will be the first to describe the extent of the information regarding the development of hearing loss in the MPS IVA population. The data gathered by this review may lead to an understanding of the grade of hearing loss in this population and allow for the assessment of possible interventions according to the disease pattern. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/32986.

Centro de Investigaciones Clinicas Fundación Valle del Lili Cali Colombia

Department of Basic Medical Sciences Center for Research on Congenital Anomalies and Rare Diseases Universidad Icesi Cali Colombia

Department of ENT University Hospital Kralovske Vinohrady and 3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Pediatrics and Inherited Metabolic Disorders General University Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Pediatrics Thomayer's University Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Hospital Universitario del Valle Cali Colombia

School of Basic Sciences Universidad del Valle Cali Colombia

Zobrazit více v PubMed

Parkinson-Lawrence EJ, Muller VJ, Hopwood JJ, Brooks DA. N-acetylgalactosamine-6-sulfatase protein detection in MPS IVA patient and unaffected control samples. Clin Chim Acta. 2007 Feb;377(1-2):88–91. doi: 10.1016/j.cca.2006.08.030.S0009-8981(06)00597-3 PubMed DOI

Tapiero-Rodriguez SM, Acosta Guio JC, Porras-Hurtado G, García N, Solano M, Pachajoa H, Velasco H. Determination of genotypic and clinical characteristics of Colombian patients with mucopolysaccharidosis IVA. Appl Clin Genet. 2018;11:45–57. doi: 10.2147/TACG.S141881. doi: 10.2147/TACG.S141881.tacg-11-045 PubMed DOI PMC

Davison JE, Kearney S, Horton J, Foster K, Peet AC, Hendriksz CJ. Intellectual and neurological functioning in Morquio syndrome (MPS IVa) J Inherit Metab Dis. 2013 Mar;36(2):323–8. doi: 10.1007/s10545-011-9430-5. PubMed DOI

Lavery C, Hendriksz C. Mortality in patients with morquio syndrome a. JIMD Rep. 2015;15:59–66. doi: 10.1007/8904_2014_298. PubMed DOI PMC

Nagao K, Morlet T, Haley E, Padilla J, Nemith J, Mason RW, Tomatsu S. Neurophysiology of hearing in patients with mucopolysaccharidosis type IV. Mol Genet Metab. 2018 Apr;123(4):472–478. doi: 10.1016/j.ymgme.2018.02.002. S1096-7192(18)30075-1 PubMed DOI PMC

Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: scoping reviews. JBI Global Wiki. 2020. [2022-03-17]. https://jbi-global-wiki.refined.site/space/MANUAL/3283910770/Chapter+11%3A+Scoping+reviews .

Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MD, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Özge, Straus SE. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018 Oct 02;169(7):467–473. doi: 10.7326/M18-0850. 2700389 PubMed DOI

Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ. 2005 Nov 05;331(7524):1064–5. doi: 10.1136/bmj.38636.593461.68. bmj.38636.593461.68 PubMed DOI PMC

Lin H, Shih S, Chuang C, Lee K, Chen M, Lin H, Chiu PC, Niu D, Lin S. Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses. Mol Genet Metab. 2014 Apr;111(4):533–8. doi: 10.1016/j.ymgme.2014.02.003.S1096-7192(14)00066-3 PubMed DOI

Murgasova L, Jurovcik M, Jesina P, Malinova V, Bloomfield M, Zeman J, Magner M. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis. Int J Pediatr Otorhinolaryngol. 2020 Aug;135:110137. doi: 10.1016/j.ijporl.2020.110137.S0165-5876(20)30280-9 PubMed DOI

Riedner ED, Levin LS. Hearing patterns in Morquio's syndrome (mucopolysaccharidosis IV) Arch Otolaryngol. 1977 Sep;103(9):518–20. doi: 10.1001/archotol.1977.00780260048003. PubMed DOI

Swartz DJ, Santi PA. Immunohistochemical localization of keratan sulfate in the chinchilla inner ear. Hear Res. 1997 Jul;109(1-2):92–101. doi: 10.1016/s0378-5955(97)00054-3.S0378-5955(97)00054-3 PubMed DOI

Hiramatsu M, Nakamura K. Elosulfase alfa enzyme replacement therapy attenuates disease progression in a non-ambulatory Japanese patient with Morquio A syndrome (case report) Mol Genet Metab Rep. 2017 Dec;13:76–79. doi: 10.1016/j.ymgmr.2017.09.001. S2214-4269(17)30104-0 PubMed DOI PMC

Wolfberg J, Chintalapati K, Tomatsu S, Nagao K. Hearing Loss in mucopolysaccharidoses: current knowledge and future directions. Diagnostics (Basel) 2020 Aug 04;10(8):554. doi: 10.3390/diagnostics10080554. diagnostics10080554 PubMed DOI PMC

Tomatsu S, Sawamoto K, Alméciga-Díaz CJ, Shimada T, Bober MB, Chinen Y, Yabe H, Montaño AM, Giugliani R, Kubaski F, Yasuda E, Rodríguez-López A, Espejo-Mojica AJ, Sánchez OF, Mason RW, Barrera LA, Mackenzie WG, Orii T. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome. Drug Des Devel Ther. 2015;9:1937–53. doi: 10.2147/DDDT.S68562. doi: 10.2147/DDDT.S68562.dddt-9-1937 PubMed DOI PMC

Chinen Y, Higa T, Tomatsu S, Suzuki Y, Orii T, Hyakuna N. Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA. Mol Genet Metab Rep. 2014;1:31–41. doi: 10.1016/j.ymgmr.2013.11.002. S2214-4269(13)00010-4 PubMed DOI PMC

Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, Shintaku H, Suzuki Y, Orii T, Tomatsu S. Hematopoietic stem cell transplantation for Morquio A syndrome. Mol Genet Metab. 2016 Feb;117(2):84–94. doi: 10.1016/j.ymgme.2015.09.011. S1096-7192(15)30057-3 PubMed DOI PMC

Nagao K, Walter C, Parkes WJ, Teixido M, Theroux MC, Szymkowski S, Morlet T, Tomatsu S. Cochlear implantation in a patient with mucopolysaccharidosis IVA. SAGE Open Med Case Rep. 2019;7:2050313X19873791. doi: 10.1177/2050313X19873791. 10.1177_2050313X19873791 PubMed DOI PMC

Hearing loss in patients with Morquio A syndrome: A scoping review